YC W24
Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
About
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Founders
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Velorum Therapeutics.
See family office activityIndustry & Focus
HealthcareTherapeuticsBiotechDrug discoveryOncology